Exploring the efficacy of mineral group remedies in case of bronchial asthma by using Lara Asthma Symptom Scale ( LASS ) : A prospective study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Efficacy of mineral group remedies in case of bronchial asthma
研究概览
简要总结
Asthma is a chronic inflammatory respiratory disease causing cough, wheezing, breathlessness, and chest tightness. It is a major global health problem, often underdiagnosed and undertreated, contributing significantly to disability and reduced quality of life. Conventional treatments control symptoms but have limitations and side effects.
Homoeopathy offers individualized treatment, and mineral group remedies are considered especially useful in chronic conditions like bronchial asthma due to their deep and long-acting nature. Remedies such as Arsenicum album, Antimonium tartaricum, Natrum sulphuricum, Kali carbonicum, and others are frequently indicated.
This prospective clinical study aims to evaluate the efficacy of mineral remedies in bronchial asthma using the Lara Asthma Symptom Scale (LASS) as an assessment tool. Patients aged 15–45 years diagnosed with bronchial asthma will be included, while those with other major respiratory or systemic diseases will be excluded. Assessment will be based on LASS scores before and after treatment, with data analyzed using the paired t-test.
The study is expected to provide evidence on the role of mineral remedies in improving symptom severity and quality of life in bronchial asthma patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 15.00 Year(s) 至 45.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Diagnostic Criteria were mainly based on Clinical history , presentation of complain and Laboratory Examination Findings .
- •2.Diagnosed case under treatment , want to shift towards Homoeopathy by consent .
- •3.Specific Age : Age between 15 – 45 years 4.Sex : both the sexes 5.Exacerbation History within the last 3-12 months .
排除标准
- •1.Other Respiratory disease condition like COPD , Interstitial lung Disease , Cystic fibrosis of lung .
- •2.Recent sever exacerbation – History of Severe Asthma , ICU admit in past 4 to 6 weeks , for Asthma last 4 weeks .
- •3.Other Major diseases like CVS , DM , CNS , Malignant and Autoimmune Diseases 4.Recent Respiratory Infection like Pneumonia , TB in last 4 months .
- •5.Pregnant and Lactating Woman.
结局指标
主要结局
Efficacy of mineral group remedies in case of bronchial asthma
时间窗: AROUND 3 TO 6 MONTHS
次要结局
- Decrease in LASS Score Towards 0(Around 3 to 6 Months)
研究者
Adhvaryu Rinkal Chetanbhai
Rajkot Homoeopathic Medical College